Our approach

 

 

Clinical if observation is at the origin of the discovery of a new therapeutic class.

 

This allows us to be particularly confident for the development of our molecules in inflammatory respiratory diseases. 

 

Thanks to our scientific collaborations we can develop new therapeutic strategies for orphan diseases.